AIS
ARRY

AlphaOne Investment Services’s Array Biopharma Inc ARRY Stock Holding History

AlphaOne Investment Services’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-2,570
Closed -$33K – 484
2017
Q4 		$33K Hold
2,570
– – 0.01% 237
2017
Q3 		$32K Buy
+2,570
New +$23.9K 0.01% 235

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

AlphaOne Investment Services's ARRY Position: Q1 2018 in Review

AlphaOne Investment Services sold out of Array Biopharma Inc (ARRY) in Q1 2018, closing a stake of 2,570 shares — an estimated $33K sold.

AlphaOne Investment Services first reported a position in ARRY in Q3 2017 and held it in 2 quarters. The position peaked at $33K in Q4 2017. 235 funds tracked by Wall St. Rank hold ARRY as of Q1 2018.

  • AlphaOne Investment Services reported no remaining Array Biopharma Inc position as of Q1 2018 after selling out during the quarter.
  • AlphaOne Investment Services sold 2,570 Array Biopharma Inc shares in Q1 2018, an estimated $33K.
  • AlphaOne Investment Services first reported a position in Array Biopharma Inc in Q3 2017 and held it in 2 quarters.
  • AlphaOne Investment Services's Array Biopharma Inc position peaked at $33K in Q4 2017.
  • 235 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q1 2018.

Based on AlphaOne Investment Services's 13F filing for Q1 2018, filed 14 May 2018.